Check Before You Invest : Brawn Biotech Ltd

BSE: 530207 NSE: ISIN: INE899B01015

| Sector: Miscellaneous | Industry: Trading

Snapshot

Q.1 Which industry/sub-sector does Brawn Biotech Ltd belong to?

Brawn Biotech Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.

Q.2 Is Brawn Biotech Ltd a good quality company?

Brawn Biotech Ltd is a quality company, based on a 10-year financial track record.

Q.3 Is Brawn Biotech Ltd undervalued or overvalued?

Brawn Biotech Ltd appears Fair, as its key valuation ratios are in line with their past averages.

Q.4 Is Brawn Biotech Ltd a good buy now?

Brawn Biotech Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Brawn Biotech Ltd?

Brawn Biotech Ltd revenue growth is -18.3% for FY-2025, which is above its 5-year CAGR of -22.96%, indicating faster growth.

Q.2 Return on capital employed (ROCE) of Brawn Biotech Ltd?

Brawn Biotech Ltd Return on capital employed is -42.59% for FY-2025, which is below its 5-year historical median of -25.66%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.3 Return on Asset of Brawn Biotech Ltd?

Brawn Biotech Ltd Return on Asset is -10.2%, which is below its 5-year historical median of -8.75%, indicating deteriorated asset utilization efficiency.

Q.4 Return on Equity (ROE) of Brawn Biotech Ltd?

Brawn Biotech Ltd Return on equity is -41.3% for FY-2025, which is below its 5-year historical median of -20.53%, indicating the business is making worse use of its shareholders capital.

Q.5 Cash conversion cycle of Brawn Biotech Ltd?

Brawn Biotech Ltd Cash conversion cycle is 185 days, above its 5-year historical median of 99 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover	0.79	1.16
ROE	-41.3	-20.53
ROCE	-42.59	-25.66
Cash Conversion Cycle	185 days	99 days

Q.6 Gross Profit margin of Brawn Biotech Ltd?

Brawn Biotech Ltd Gross profit margin which is the profit after deduction of direct costs, is -12.5% for FY-2025, which is below its 5-year median of -8.8%, indicating decreasing margins.

Q.7 Operating Profit Margin of Brawn Biotech Ltd?

Brawn Biotech Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -13.16% for FY-2025, which is below its 5-year median of -8.88% indicating decreasing margins.

Q.8 Net Profit Margin of Brawn Biotech Ltd?

Brawn Biotech Ltd Net Profit Margin is -12.92% for FY-2025, is below with its 5-year median of -7.56%, indicating decreasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin	-12.5	-8.8
Operating Profit Margin	-13.16	-8.88
Net Profit Margin	-12.92	-7.56

Q.9 Debt to Equity ratio of Brawn Biotech Ltd?

Brawn Biotech Ltd Debt-to-Equity ratio is 0.00, which is lower with the industry average of 0.17, indicating lower debt levels in the industry.

Q.10 Debt to cash flow from operations of Brawn Biotech Ltd?

Brawn Biotech Ltd Debt to cash flow from operations is 0, which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Brawn Biotech Ltd?

Promoters hold 52.94% of the Brawn Biotech Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Brawn Biotech Ltd vs industry peers?

Brawn Biotech Ltd revenue CAGR is -22.96%, compared to the industry median CAGR of 12.68%, indicating slower growth and losing its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	-18.3	12.7
Gross Profit Growth	0	18.5
Operating Profit Growth	0	15.2
Net Profit Growth	0	16.5

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	0.79	0.81
ROE	-41.3	2.6
ROCE	-42.59	3.8
Cash Conversion Cycle (days)	184.85	61

Valuation & price assessment

Q.1 Stock return of Brawn Biotech Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -8.2% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	-8.2%	-7.9%	7.1%	16.1%

Q.3 Valuation ratios of Brawn Biotech Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	-	13.75	33.44
Price to Book	1.58	1.01	1.58
Price to Sales	0.34	0.35	2.20
EV to EBITDA	-522.87	-4.33	14.05

Check more companies

3. Redington

6. Lloyds Enterprises

7. MMTC

8. Cello World

9. Jeena Sikho Life

10. SG Mart

Check trending companies

1. Hexaware Technologies Ltd.

2. Newgen Software Technologies Ltd.

3. LTM Ltd.

4. Sona BLW Precision Forgings Ltd.

5. Motilal Oswal Financial Services Ltd.